FABP4 and breast cancer: It was demonstrated that CAAs surrounding breast cancer are smaller and exhibit lower lipid content, reduced levels of adipocyte markers (leptin, adiponectin, resistin, FABP4), and overexpression of proinflammatory cytokines and matrix-remodeling proteins [43–46].